ANS Genesis Totally Implantable Spinal Cord Stimulator Gains FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Advanced Neuromodulation Systems says it will launch its Genesis totally implantable pulse generator (IPG) spinal cord stimulation (SCS) system in January. FDA approval of the device was announced Nov. 21
You may also be interested in...
Advanced Bionics Defers Current Profits To Stimulate Neurostimulation
Advanced Bionics is investing in implantable neurostimulators to extend beyond its initial product segment in cochlear implants. The Sylmar, California company is predicting the start of clinical trials on neurostimulators for urge incontinence and pain by the end of this year
Advanced Bionics Defers Current Profits To Stimulate Neurostimulation
Advanced Bionics is investing in implantable neurostimulators to extend beyond its initial product segment in cochlear implants. The Sylmar, California company is predicting the start of clinical trials on neurostimulators for urge incontinence and pain by the end of this year
ANS PMA For Genesis SCS System Relies on Clinical Literature Studies
Advanced Neuromodulation Systems supported the efficacy of its recently approved Genesis implantable spinal cord stimulator (SCS) using three clinical studies performed with Medtronic's SCS system